Seeking Alpha

Rosetta Genomics rallies on deal with mystery major

  • Rosetta Genomics (ROSG) soars 25% premarket.
  • The company says it has "signed a master service provider agreement with an undisclosed major global biopharmaceutical company."
  • The deal calls for ROSG to "provide its microRNA profiling and other services pursuant to a collaboration in important areas of unmet medical need." (PR)
Comments (2)
  • rcpatrick5443
    , contributor
    Comments (678) | Send Message
    Good for ROSG, its new collaborator, and its patient investors.
    13 Jan, 08:32 AM Reply Like
  • Jonathan Bluhm
    , contributor
    Comments (392) | Send Message
    Love this news today. A sign of good things to come for ROSG in 2014.
    13 Jan, 09:37 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: